| NCT ID | NCT03692884 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chongqing Medical University |
| Condition | Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2018-07-01 |
| Primary Completion | 2030-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2018-07-01 with a primary completion date of 2030-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the risk factors and biomarkers of the microvascular disease，macrovascular disease and neuropathy in patients with diabetes.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of diabetes mellitus（based on the 1999 WHO diagnostic cretirial）; 2. Age younger than 75 years old, gender is not limited; 3. Voluntary to sign on the informed consent. Exclusion Criteria: 1. pregnant or breast-feeding women; 2. Patients with chronic disease requiring long-term glucocorticoid therapy; 3. Patients with severe infection (except for diabetic foot) or immune dysfunction.
Contact & Investigator
Qifu Li, phD
STUDY CHAIR
First Affiliated Hospital of Chongqing Medical University
Frequently Asked Questions
Who can join the NCT03692884 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03692884 currently recruiting?
Yes, NCT03692884 is actively recruiting participants. Contact the research team at liqifu@yeah.net for enrollment information.
Where is the NCT03692884 trial being conducted?
This trial is being conducted at Chongqing, China.
Who is sponsoring the NCT03692884 clinical trial?
NCT03692884 is sponsored by Chongqing Medical University. The principal investigator is Qifu Li, phD at First Affiliated Hospital of Chongqing Medical University. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.